HEADER OXIDOREDUCTASE 29-NOV-06 2O1Q TITLE CRYSTAL STRUCTURE OF A PUTATIVE ACETYLACETONE DIOXYGENASE (MPE_A3659) TITLE 2 FROM METHYLIBIUM PETROLEIPHILUM PM1 AT 1.50 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE ACETYL/PROPIONYL-COA CARBOXYLASE, ALPHA SUBUNIT; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: METHYLIBIUM PETROLEIPHILUM; SOURCE 3 ORGANISM_TAXID: 420662; SOURCE 4 STRAIN: PM1; SOURCE 5 GENE: ZP_00243239.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 OTHER_DETAILS: METHYLOBIUM PETROLEOPHILUM IS ANOTHER SCIENTIFIC NAME SOURCE 10 OF THE SOURCE ORGANISM KEYWDS PUTATIVE ACETYLACETONE DIOXYGENASE, STRUCTURAL GENOMICS, JOINT CENTER KEYWDS 2 FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 7 27-DEC-23 2O1Q 1 REMARK LINK REVDAT 6 25-OCT-17 2O1Q 1 REMARK REVDAT 5 18-OCT-17 2O1Q 1 REMARK REVDAT 4 13-JUL-11 2O1Q 1 VERSN REVDAT 3 28-JUL-10 2O1Q 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2O1Q 1 VERSN REVDAT 1 23-JAN-07 2O1Q 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE ACETYL/PROPIONYL-COA JRNL TITL 2 CARBOXYLASE, ALPHA SUBUNIT (ZP_00243239.1) FROM RUBRIVIVAX JRNL TITL 3 GELATINOSUS PM1 (METHYLOBIUM PETROLEOPHILUM PM1) AT 1.50 A JRNL TITL 4 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 42575 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2177 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2892 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.36 REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE SET COUNT : 174 REMARK 3 BIN FREE R VALUE : 0.2690 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2170 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 202 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 16.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.28000 REMARK 3 B22 (A**2) : 0.28000 REMARK 3 B33 (A**2) : -0.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.080 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.080 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.058 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.939 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2373 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1577 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3219 ; 1.706 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3843 ; 0.935 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 304 ; 7.000 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 91 ;36.395 ;23.846 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 324 ;12.429 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;14.698 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 320 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2724 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 499 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 498 ; 0.233 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1517 ; 0.202 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1142 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1260 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 171 ; 0.229 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 9 ; 0.215 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 29 ; 0.162 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 115 ; 0.248 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 30 ; 0.215 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1549 ; 2.194 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 606 ; 0.628 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2382 ; 2.784 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 997 ; 4.311 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 837 ; 5.221 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 144 REMARK 3 ORIGIN FOR THE GROUP (A): 22.3432 19.4367 10.2985 REMARK 3 T TENSOR REMARK 3 T11: -0.0494 T22: -0.0291 REMARK 3 T33: -0.0321 T12: 0.0044 REMARK 3 T13: -0.0008 T23: 0.0216 REMARK 3 L TENSOR REMARK 3 L11: 0.7504 L22: 0.6749 REMARK 3 L33: 0.5351 L12: 0.1842 REMARK 3 L13: -0.1371 L23: 0.0802 REMARK 3 S TENSOR REMARK 3 S11: 0.0434 S12: -0.1075 S13: -0.0382 REMARK 3 S21: 0.0526 S22: -0.0274 S23: 0.0217 REMARK 3 S31: 0.0337 S32: 0.0314 S33: -0.0161 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 144 REMARK 3 ORIGIN FOR THE GROUP (A): 40.6623 40.6750 10.6169 REMARK 3 T TENSOR REMARK 3 T11: -0.0305 T22: 0.0069 REMARK 3 T33: -0.0241 T12: -0.0103 REMARK 3 T13: 0.0123 T23: -0.0421 REMARK 3 L TENSOR REMARK 3 L11: 0.7783 L22: 0.6590 REMARK 3 L33: 0.7851 L12: 0.2391 REMARK 3 L13: 0.0865 L23: 0.1084 REMARK 3 S TENSOR REMARK 3 S11: 0.0641 S12: -0.1477 S13: 0.0389 REMARK 3 S21: 0.0210 S22: 0.0062 S23: -0.0406 REMARK 3 S31: -0.0990 S32: 0.1137 S33: -0.0703 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: (1). HYDROGENS HAVE BEEN ADDED IN REMARK 3 RIDING POSITIONS. (2). ATOM RECORD CONTAINS RESIDUAL B FACTORS REMARK 3 ONLY. (3). A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. (4). A ZN ATOM ON EACH OF THE TWO SUBUNITS REMARK 3 IN THE ASYMMETRIC UNIT IS COORDINATED TO THE SIDE CHAIN OF HIS REMARK 3 59, HIS 101, AND ACETATE. A ZINC ATOM ON SUBUNIT B IS REMARK 3 COORDINATED TO THE SIDE CHAINS OF GLU 136, ASP 137 AND FOUR REMARK 3 WATER MOLECULES. ANOMALOUS DIFFERENCE FOURIERS AND X-RAY REMARK 3 FLUORESCENCE EXPERIMENTS SUPPORT THE ASSIGNMENT OF THE ZINC REMARK 3 IONS. (5). UNEXPLAINED ELECTRON DENSITIES OBSERVED NEAR RESIDUE REMARK 3 111 ON THE A SUBUNIT AND RESIDUES 141-143 ON THE B SUBUNIT WERE REMARK 3 NOT MODELED. (6). FOUR MOLECULES OF POLYETHYLENE GLYCOL 200 (PG4) REMARK 3 USED AS A CRYOPROTECTANT, FIVE ACETATE (ACT) AND ONE CL ION REMARK 3 FROM THE CRYSTALLIZATION BUFFER WERE MODELED INTO THE STRUCTURE. REMARK 4 REMARK 4 2O1Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040576. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-06; 20-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : SSRL; APS REMARK 200 BEAMLINE : BL1-5; 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000017; 0.97942, 0.97921, REMARK 200 0.94645 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR; SI(111) DOUBLE REMARK 200 CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : 1M LONG RH COATED BENT REMARK 200 CYLINDRICAL MIRROR FORHORIZONTAL REMARK 200 AND VERTICAL FOCUSSING; REMARK 200 ADJUSTABLE FOCUSING MIRRORS IN K- REMARK 200 B GEOMETRY REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315; MARMOSAIC 300 REMARK 200 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42659 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.437 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.73200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: DATA FROM TWO CRYSTALS WERE USED FOR THE STRUCTURE REMARK 200 DETERMINATION. ONE CRYSTAL WAS USED FOR MAD PHASING EXPERIMENTS REMARK 200 AND TRACING AT A RESOLUTION OF 2.0 ANGTROMS. THE 2.0 ANGSTROM REMARK 200 MODEL WAS REFINED TO AN ENHANCED RESOLUTION OF 1.50 ANGSTROMS REMARK 200 USING DATA FROM A SEPARATE CRYSTAL WITH THE 2 ANGSTROM MAD REMARK 200 PHASES FROM THE FIRST CRYSTAL USED AS PHASE RESTRAINTS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.0% PEG-1000, 0.2M ZN(OAC)2, 0.1M REMARK 280 ACETATE PH 4.5, VAPOR DIFFUSION, SITTING DROP, NANODROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.90000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 31.01000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 31.01000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.45000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 31.01000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 31.01000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 100.35000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 31.01000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.01000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 33.45000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 31.01000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.01000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 100.35000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 66.90000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT REMARK 300 SCATTERING SUPPORTS A MIXTURE OF DIMER AND TETRAMER REMARK 300 IN SOLUTION. THE PISA SERVER ALSO PREDICTS BOTH THE REMARK 300 TETRAMER AND DIMER TO BE STABLE. THE TETRAMER IS REMARK 300 DESCRIBED IN REMARK 350. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 16580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -308.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLY B 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 7 CD CE NZ REMARK 470 LYS A 71 CD CE NZ REMARK 470 LYS A 73 NZ REMARK 470 LYS A 80 CG CD CE NZ REMARK 470 ARG A 100 CD NE CZ NH1 NH2 REMARK 470 MSE B 1 SE CE REMARK 470 LYS B 5 NZ REMARK 470 LYS B 7 CD CE NZ REMARK 470 LYS B 73 CD CE NZ REMARK 470 LYS B 80 CE NZ REMARK 470 LYS B 103 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 95 CD GLU A 95 OE2 0.102 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 98 -3.70 83.86 REMARK 500 LYS A 103 80.75 -160.02 REMARK 500 LYS B 103 84.13 -156.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PG4 A 151 REMARK 610 PG4 A 152 REMARK 610 PG4 B 149 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 145 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 59 NE2 REMARK 620 2 HIS A 61 NE2 107.2 REMARK 620 3 HIS A 101 ND1 116.2 89.5 REMARK 620 4 ACT A 149 OXT 122.8 98.0 114.4 REMARK 620 5 ACT A 149 OXT 129.6 111.3 95.5 22.5 REMARK 620 6 ACT A 149 O 88.0 159.0 96.6 61.2 48.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 145 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 59 NE2 REMARK 620 2 HIS B 61 NE2 107.9 REMARK 620 3 HIS B 101 ND1 108.0 92.8 REMARK 620 4 ACT B 147 O 83.5 163.3 95.1 REMARK 620 5 ACT B 147 O 109.7 142.0 70.4 31.7 REMARK 620 6 ACT B 147 OXT 144.1 101.0 91.0 64.2 47.7 REMARK 620 7 ACT B 147 OXT 121.3 101.1 120.4 62.3 63.3 29.6 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 146 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 136 OE2 REMARK 620 2 ASP B 137 OD2 93.1 REMARK 620 3 HOH B 164 O 85.5 89.2 REMARK 620 4 HOH B 179 O 100.8 92.9 173.2 REMARK 620 5 HOH B 203 O 73.7 166.6 87.3 92.0 REMARK 620 6 HOH B 237 O 160.4 104.3 85.8 87.4 88.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 146 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 146 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 148 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 149 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 148 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 150 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 149 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 151 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 152 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 370490 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE: REMARK 999 (1) THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION REMARK 999 TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET REMARK 999 SEQUENCE. REMARK 999 (2) THE SEQUENCE OF THE PROTEIN WAS NOT AVAILABLE AT THE REMARK 999 UNP DATABASE AT THE TIME OF PROCESSING. REMARK 999 (3) THE SEQUENCE IS AVAILABLE FROM GENBANK UNDER ACCESSION REMARK 999 ID ZP_00243239.1 AND FROM THE UNIPROT ARCHIVE UNDER REMARK 999 ACCESSION ID UPI00003CCEF6. DBREF 2O1Q A 0 144 PDB 2O1Q 2O1Q 0 144 DBREF 2O1Q B 0 144 PDB 2O1Q 2O1Q 0 144 SEQRES 1 A 145 GLY MSE LEU LYS SER LYS ILE LYS GLU GLU TYR VAL GLN SEQRES 2 A 145 MSE ASP GLN VAL ASP TRP LYS PRO PHE PRO ALA ALA PHE SEQRES 3 A 145 SER THR GLY GLY ILE ARG TRP LYS LEU LEU HIS VAL SER SEQRES 4 A 145 PRO GLU MSE GLY SER TRP THR ALA ILE PHE ASP CYS PRO SEQRES 5 A 145 ALA GLY SER SER PHE ALA ALA HIS VAL HIS VAL GLY PRO SEQRES 6 A 145 GLY GLU TYR PHE LEU THR LYS GLY LYS MSE ASP VAL ARG SEQRES 7 A 145 GLY GLY LYS ALA ALA GLY GLY ASP THR ALA ILE ALA PRO SEQRES 8 A 145 GLY TYR GLY TYR GLU SER ALA ASN ALA ARG HIS ASP LYS SEQRES 9 A 145 THR GLU PHE PRO VAL ALA SER GLU PHE TYR MSE SER PHE SEQRES 10 A 145 LEU GLY PRO LEU THR PHE VAL LYS PRO ASP GLY SER PRO SEQRES 11 A 145 ILE ALA VAL ILE GLY TRP GLU ASP ALA GLN GLY ALA TRP SEQRES 12 A 145 ALA ALA SEQRES 1 B 145 GLY MSE LEU LYS SER LYS ILE LYS GLU GLU TYR VAL GLN SEQRES 2 B 145 MSE ASP GLN VAL ASP TRP LYS PRO PHE PRO ALA ALA PHE SEQRES 3 B 145 SER THR GLY GLY ILE ARG TRP LYS LEU LEU HIS VAL SER SEQRES 4 B 145 PRO GLU MSE GLY SER TRP THR ALA ILE PHE ASP CYS PRO SEQRES 5 B 145 ALA GLY SER SER PHE ALA ALA HIS VAL HIS VAL GLY PRO SEQRES 6 B 145 GLY GLU TYR PHE LEU THR LYS GLY LYS MSE ASP VAL ARG SEQRES 7 B 145 GLY GLY LYS ALA ALA GLY GLY ASP THR ALA ILE ALA PRO SEQRES 8 B 145 GLY TYR GLY TYR GLU SER ALA ASN ALA ARG HIS ASP LYS SEQRES 9 B 145 THR GLU PHE PRO VAL ALA SER GLU PHE TYR MSE SER PHE SEQRES 10 B 145 LEU GLY PRO LEU THR PHE VAL LYS PRO ASP GLY SER PRO SEQRES 11 B 145 ILE ALA VAL ILE GLY TRP GLU ASP ALA GLN GLY ALA TRP SEQRES 12 B 145 ALA ALA MODRES 2O1Q MSE A 1 MET SELENOMETHIONINE MODRES 2O1Q MSE A 13 MET SELENOMETHIONINE MODRES 2O1Q MSE A 41 MET SELENOMETHIONINE MODRES 2O1Q MSE A 74 MET SELENOMETHIONINE MODRES 2O1Q MSE A 114 MET SELENOMETHIONINE MODRES 2O1Q MSE B 1 MET SELENOMETHIONINE MODRES 2O1Q MSE B 13 MET SELENOMETHIONINE MODRES 2O1Q MSE B 41 MET SELENOMETHIONINE MODRES 2O1Q MSE B 74 MET SELENOMETHIONINE MODRES 2O1Q MSE B 114 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 13 8 HET MSE A 41 8 HET MSE A 74 8 HET MSE A 114 8 HET MSE B 1 6 HET MSE B 13 8 HET MSE B 41 8 HET MSE B 74 16 HET MSE B 114 16 HET ZN A 145 1 HET CL A 146 1 HET ACT A 147 4 HET ACT A 148 4 HET ACT A 149 8 HET PG4 A 150 13 HET PG4 A 151 6 HET PG4 A 152 18 HET ZN B 145 1 HET ZN B 146 1 HET ACT B 147 8 HET ACT B 148 4 HET PG4 B 149 6 HETNAM MSE SELENOMETHIONINE HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 3 ZN 3(ZN 2+) FORMUL 4 CL CL 1- FORMUL 5 ACT 5(C2 H3 O2 1-) FORMUL 8 PG4 4(C8 H18 O5) FORMUL 16 HOH *202(H2 O) HELIX 1 1 GLN A 12 VAL A 16 5 5 HELIX 2 2 PRO A 22 ALA A 24 5 3 HELIX 3 3 GLY A 79 GLY A 83 5 5 HELIX 4 4 GLY A 134 ALA A 144 1 11 HELIX 5 5 GLN B 12 VAL B 16 5 5 HELIX 6 6 PRO B 22 ALA B 24 5 3 HELIX 7 7 GLY B 79 GLY B 83 5 5 HELIX 8 8 GLY B 134 ALA B 144 1 11 SHEET 1 A 6 LYS A 19 PRO A 20 0 SHEET 2 A 6 ARG A 31 SER A 38 -1 O TRP A 32 N LYS A 19 SHEET 3 A 6 SER A 43 CYS A 50 -1 O SER A 43 N SER A 38 SHEET 4 A 6 GLU A 105 LEU A 117 -1 O MSE A 114 N ALA A 46 SHEET 5 A 6 GLY A 65 VAL A 76 -1 N ASP A 75 O GLU A 105 SHEET 6 A 6 ASP A 85 ILE A 88 -1 O ALA A 87 N MSE A 74 SHEET 1 B 5 SER A 26 THR A 27 0 SHEET 2 B 5 SER A 54 PHE A 56 -1 O SER A 55 N THR A 27 SHEET 3 B 5 GLU A 105 LEU A 117 -1 O PHE A 106 N SER A 54 SHEET 4 B 5 GLY A 65 VAL A 76 -1 N ASP A 75 O GLU A 105 SHEET 5 B 5 GLY A 91 GLU A 95 -1 O GLY A 91 N LEU A 69 SHEET 1 C 4 ARG A 100 HIS A 101 0 SHEET 2 C 4 HIS A 59 HIS A 61 -1 N HIS A 59 O HIS A 101 SHEET 3 C 4 LEU A 120 VAL A 123 -1 O THR A 121 N VAL A 60 SHEET 4 C 4 PRO A 129 ILE A 133 -1 O ILE A 130 N PHE A 122 SHEET 1 D 6 LYS B 19 PRO B 20 0 SHEET 2 D 6 ARG B 31 SER B 38 -1 O TRP B 32 N LYS B 19 SHEET 3 D 6 SER B 43 CYS B 50 -1 O SER B 43 N SER B 38 SHEET 4 D 6 GLU B 105 LEU B 117 -1 O SER B 110 N CYS B 50 SHEET 5 D 6 GLY B 65 VAL B 76 -1 N PHE B 68 O TYR B 113 SHEET 6 D 6 ASP B 85 ILE B 88 -1 O ALA B 87 N MSE B 74 SHEET 1 E 6 LYS B 19 PRO B 20 0 SHEET 2 E 6 ARG B 31 SER B 38 -1 O TRP B 32 N LYS B 19 SHEET 3 E 6 SER B 43 CYS B 50 -1 O SER B 43 N SER B 38 SHEET 4 E 6 GLU B 105 LEU B 117 -1 O SER B 110 N CYS B 50 SHEET 5 E 6 GLY B 65 VAL B 76 -1 N PHE B 68 O TYR B 113 SHEET 6 E 6 GLY B 91 GLU B 95 -1 O GLU B 95 N GLY B 65 SHEET 1 F 2 SER B 26 THR B 27 0 SHEET 2 F 2 SER B 55 PHE B 56 -1 O SER B 55 N THR B 27 SHEET 1 G 4 ARG B 100 HIS B 101 0 SHEET 2 G 4 HIS B 59 HIS B 61 -1 N HIS B 59 O HIS B 101 SHEET 3 G 4 LEU B 120 VAL B 123 -1 O THR B 121 N VAL B 60 SHEET 4 G 4 PRO B 129 ILE B 133 -1 O ILE B 133 N LEU B 120 LINK C MSE A 1 N LEU A 2 1555 1555 1.34 LINK C GLN A 12 N MSE A 13 1555 1555 1.31 LINK C MSE A 13 N ASP A 14 1555 1555 1.33 LINK C GLU A 40 N MSE A 41 1555 1555 1.34 LINK C MSE A 41 N GLY A 42 1555 1555 1.34 LINK C LYS A 73 N MSE A 74 1555 1555 1.33 LINK C MSE A 74 N ASP A 75 1555 1555 1.32 LINK C TYR A 113 N MSE A 114 1555 1555 1.33 LINK C MSE A 114 N ASER A 115 1555 1555 1.32 LINK C MSE A 114 N BSER A 115 1555 1555 1.33 LINK C MSE B 1 N LEU B 2 1555 1555 1.34 LINK C GLN B 12 N MSE B 13 1555 1555 1.33 LINK C MSE B 13 N ASP B 14 1555 1555 1.32 LINK C GLU B 40 N MSE B 41 1555 1555 1.33 LINK C MSE B 41 N GLY B 42 1555 1555 1.32 LINK C LYS B 73 N AMSE B 74 1555 1555 1.33 LINK C LYS B 73 N BMSE B 74 1555 1555 1.33 LINK C BMSE B 74 N ASP B 75 1555 1555 1.33 LINK C AMSE B 74 N ASP B 75 1555 1555 1.33 LINK C TYR B 113 N BMSE B 114 1555 1555 1.32 LINK C TYR B 113 N AMSE B 114 1555 1555 1.32 LINK C BMSE B 114 N SER B 115 1555 1555 1.33 LINK C AMSE B 114 N SER B 115 1555 1555 1.33 LINK NE2 HIS A 59 ZN ZN A 145 1555 1555 1.98 LINK NE2 HIS A 61 ZN ZN A 145 1555 1555 2.08 LINK ND1 HIS A 101 ZN ZN A 145 1555 1555 1.69 LINK ZN ZN A 145 OXTAACT A 149 1555 1555 1.81 LINK ZN ZN A 145 OXTBACT A 149 1555 1555 2.53 LINK ZN ZN A 145 O AACT A 149 1555 1555 2.22 LINK NE2 HIS B 59 ZN ZN B 145 1555 1555 2.06 LINK NE2 HIS B 61 ZN ZN B 145 1555 1555 2.04 LINK ND1 HIS B 101 ZN ZN B 145 1555 1555 1.71 LINK OE2 GLU B 136 ZN ZN B 146 1555 1555 2.00 LINK OD2 ASP B 137 ZN ZN B 146 1555 1555 2.08 LINK ZN ZN B 145 O AACT B 147 1555 1555 2.23 LINK ZN ZN B 145 O BACT B 147 1555 1555 2.68 LINK ZN ZN B 145 OXTBACT B 147 1555 1555 2.47 LINK ZN ZN B 145 OXTAACT B 147 1555 1555 1.70 LINK ZN ZN B 146 O HOH B 164 1555 1555 2.28 LINK ZN ZN B 146 O HOH B 179 1555 1555 2.19 LINK ZN ZN B 146 O HOH B 203 1555 1555 2.48 LINK ZN ZN B 146 O HOH B 237 1555 1555 1.95 CISPEP 1 ALA A 89 PRO A 90 0 -7.36 CISPEP 2 ALA B 89 PRO B 90 0 -5.89 SITE 1 AC1 4 HIS A 59 HIS A 61 HIS A 101 ACT A 149 SITE 1 AC2 4 HIS B 59 HIS B 61 HIS B 101 ACT B 147 SITE 1 AC3 7 VAL B 132 GLU B 136 ASP B 137 HOH B 164 SITE 2 AC3 7 HOH B 179 HOH B 203 HOH B 237 SITE 1 AC4 7 GLY A 134 TRP A 135 GLU A 136 ASP A 137 SITE 2 AC4 7 HOH A 203 ASN B 98 HOH B 201 SITE 1 AC5 2 ARG A 31 ASP A 102 SITE 1 AC6 6 PRO A 22 ILE A 133 ASP A 137 ALA A 138 SITE 2 AC6 6 ALA A 141 HOH A 233 SITE 1 AC7 7 HIS B 59 HIS B 61 HIS B 101 THR B 104 SITE 2 AC7 7 PHE B 112 MSE B 114 ZN B 145 SITE 1 AC8 6 HIS A 59 HIS A 61 HIS A 101 THR A 104 SITE 2 AC8 6 MSE A 114 ZN A 145 SITE 1 AC9 2 PHE B 68 GLU B 111 SITE 1 BC1 7 GLU A 9 LYS A 19 LEU A 34 HIS A 36 SITE 2 BC1 7 VAL A 37 TRP A 142 LYS B 3 SITE 1 BC2 5 ILE B 6 GLU B 8 ARG B 100 HOH B 150 SITE 2 BC2 5 HOH B 234 SITE 1 BC3 7 MSE A 1 LEU A 2 ASP A 75 LYS A 103 SITE 2 BC3 7 GLU A 105 HOH A 245 HOH A 247 SITE 1 BC4 10 SER A 4 LYS A 5 ILE A 6 LYS A 7 SITE 2 BC4 10 GLU A 8 THR A 27 GLY A 28 GLY A 29 SITE 3 BC4 10 ARG A 77 HOH A 256 CRYST1 62.020 62.020 133.800 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016120 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016120 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007470 0.00000 HETATM 1 N MSE A 1 52.641 25.987 -6.697 1.00 40.22 N HETATM 2 CA MSE A 1 52.065 24.619 -6.892 1.00 42.15 C HETATM 3 C MSE A 1 50.716 24.654 -7.638 1.00 32.56 C HETATM 4 O MSE A 1 49.738 25.254 -7.153 1.00 28.99 O HETATM 5 CB MSE A 1 51.940 23.875 -5.549 1.00 40.89 C HETATM 6 CG MSE A 1 50.522 23.315 -5.223 1.00 48.07 C HETATM 7 SE MSE A 1 50.439 21.497 -4.462 0.75 65.69 SE HETATM 8 CE MSE A 1 51.546 20.610 -5.772 1.00 36.67 C